Regulator regrets confusion over suspected accounting breaches at Samsung BioLogics
SEOUL, May 16 (Yonhap) — The head of the nation’s top financial regulator on Wednesday expressed regret for market confusion caused by a prior notice from financial authorities that Samsung Biologics Co. allegedly breached accounting rules.
GC Pharma sets up vaccine firm in U.S.
SEOUL, May 21 (Yonhap) — South Korean drug company GC Pharma set up a vaccineRead More
Seoul shares open lower on profit taking.
SEOUL, May 21 (Yonhap) — South Korean stocks opened lower Monday as investors offloaded technologyRead More